Marketing Code of Conduct and Electronic Pedigree Information

Marketing Code of Conduct

NRS 639.233 requires any person, including a wholesaler or manufacturer, engaging in the business of wholesale distribution, or furnishing controlled substances, poisons, drugs, devices or appliances that are restricted by federal law to sale by or on the order of a physician to any person located within this State to obtain a license from the Nevada State Board of Pharmacy (Board). A person is “engaged in the business of furnishing” if the person solicits or accepts orders for drugs or devices whose sale in this State is restricted by NRS 639, 453 and 454 or receives, stores or ships such drugs or devices.”

Formerly referred to as AB 128, the Marketing Code of Conduct annual, NRS 639.570, requires a wholesaler or manufacturer who employs a person to sell or market a drug, medicine, chemical, device or appliance in Nevada to submit annually to the Board certain information regarding their Marketing Code of Conduct NAC 639.6053-6057, NAC 639.616-619, and NAC 639.69573-69577.

Please find the form to report your Marketing Code of Conduct: here.


  • Completed forms and documents must be received by the Board from May 1st through June 1st annually. Forms submitted outside this time frame are deemed non-compliant.
  • Please submit completed form and documents by:
  • This form is to be used for a wholesaler or manufacturer’s initial and annual filing of its marketing code of conduct. You do not need to complete this form if the only product or products your company markets or sells in Nevada are food, aspirin, or effervescent saline analgesics. See NRS 639.007(3).

The Board provides a report to the Governor, and to the Director of the Legislative Counsel Bureau for transmittal to the Legislature, a compilation of the information submitted to the Board pursuant to NRS 639.570, other than any information identified as a trade secret in the information submitted. Therefore, please clearly indicate on any document submitted with the form any confidential or proprietary business information subject to the disclosure protections of NRS 639.570(4)(d).


If you have any questions on the process, please contact the Board by email at or at